This content aligns with Goal 3: Good Health as well as Goal 10: Reduced Inequalities by reviewing key advances in the field of neuropathogenesis and studies that have highlighted how molecular diversity within the HIV genome may impact HIV-associated neurologic disease.
This content aligns with Goal 3: Good Health as well as Goal 10: Reduced Inequalities by examining drivers of RIDS in treated HIV infection.
Objectives: Lesbian, gay, and bisexual (LGB) populations exhibit elevated rates of psychiatric disorders compared to heterosexuals, and these disparities emerge early in the life course.
The late 1990s and early 2000s witnessed a growing interest amongst UK academics and policy makers in the issue of transport disadvantage and, more innovatively, how this might relate to growing conce
This content aligns with Goal 3: Good Health as well as Goal 10: Reduced Inequalities by presenting a better understanding of how Nef disrupts antigen presentation may lead to the development of drugs that enhance the ability of the anti-HIV CTLs to control HIV disease.
Adolescents with a minority sexual orientation (e.g., lesbian, gay, and bisexual) are more likely to use substances than their heterosexual peers.
Same-sex sexual behavior has been extensively documented in non-human animals.
This content aligns with Goal 3: Good Health as well as Goal 10: Reduced Inequalities by highlighting studies showing how HIV-1 uses exon definition to control the level of splicing at each of its 3′-splice sites.
This article explores the role of religion and cultural context in shaping attitudes about homosexuality across the globe, developing SDG 10 (reduced inequalities).
Treatment of gender-identity disorders is guided by standards set forth by the World Professional Association for Transgender Health (WPATH).